Nothing Special   »   [go: up one dir, main page]

Davison et al., 2011 - Google Patents

Functional fluorescently labeled bithiazole ΔF508-CFTR corrector imaged in whole body slices in mice

Davison et al., 2011

View HTML
Document ID
13172570625171231762
Author
Davison H
Taylor S
Drake C
Phuan P
Derichs N
Yao C
Jones E
Sutcliffe J
Verkman A
Kurth M
Publication year
Publication venue
Bioconjugate chemistry

External Links

Snippet

We previously reported the identification and structure–activity analysis of bithiazole-based correctors of defective cellular processing of the cystic fibrosis-causing CFTR mutant, ΔF508- CFTR. Here, we report the synthesis and uptake of a functional, fluorescently labeled …
Continue reading at www.ncbi.nlm.nih.gov (HTML) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5082—Supracellular entities, e.g. tissue, organisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring

Similar Documents

Publication Publication Date Title
Jin et al. Azo-PROTAC: novel light-controlled small-molecule tool for protein knockdown
Ratni et al. Specific correction of alternative survival motor neuron 2 splicing by small molecules: discovery of a potential novel medicine to treat spinal muscular atrophy
Li et al. A sensitive two-photon probe to selectively detect monoamine oxidase B activity in Parkinson’s disease models
Binda et al. Structures of human monoamine oxidase B complexes with selective noncovalent inhibitors: safinamide and coumarin analogs
Zhao et al. Photostable pH-sensitive near-infrared aggregation-induced emission luminogen for long-term mitochondrial tracking
Dai et al. A visible and near-infrared light activatable diazocoumarin probe for fluorogenic protein labeling in living cells
Papadopoulou et al. Novel 3-nitrotriazole-based amides and carbinols as bifunctional antichagasic agents
Zhang et al. Design and synthesis of a ratiometric photoacoustic probe for in situ imaging of zinc ions in deep tissue in vivo
Lee et al. BODIPY–Coumarin conjugate as an endoplasmic reticulum membrane fluidity sensor and its application to ER stress models
Reo et al. Ratiometric imaging of γ-glutamyl transpeptidase unperturbed by pH, polarity, and viscosity changes: A benzocoumarin-based two-photon fluorescent probe
Li et al. Cysteine-activatable near-infrared fluorescent probe for dual-channel tracking lipid droplets and mitochondria in epilepsy
Cürten et al. Synthesis, Photophysical, Photochemical and Biological Properties of Caged GABA, 4‐[[(2H‐1‐Benzopyran‐2‐one‐7‐amino‐4‐methoxy) carbonyl] amino] Butanoic Acid¶
Peng et al. A novel near-infrared viscosity probe based on synergistic effect of AIE property and molecular rotors for mitophagy imaging during liver injury
Henrich et al. Botryllamides: Natural product inhibitors of ABCG2
Zhang et al. Phospholipid-biomimetic fluorescent mitochondrial probe with ultrahigh selectivity enables in situ and high-fidelity tissue imaging
Harrison et al. Discovery of a series of ester-substituted NLRP3 inflammasome inhibitors
Munck af Rosenschöld et al. Discovery of the oral leukotriene C4 synthase inhibitor (1 S, 2 S)-2-({5-[(5-Chloro-2, 4-difluorophenyl)(2-fluoro-2-methylpropyl) amino]-3-methoxypyrazin-2-yl} carbonyl) cyclopropanecarboxylic acid (AZD9898) as a new treatment for asthma
Davison et al. Functional fluorescently labeled bithiazole ΔF508-CFTR corrector imaged in whole body slices in mice
Moon et al. High Stability of a Donor–Acceptor Type Oxazepine-Containing Fluorophore and Its Applications in Cellular Imaging and Two-Photon Deep Tissue Imaging
Lee et al. In vivo simultaneous imaging of plasma membrane and lipid droplets in hepatic steatosis using red-emissive two-photon probes
Maltais et al. Turning a quinoline-based steroidal anticancer agent into fluorescent dye for its tracking by cell imaging
Tassini et al. Multitarget CFTR modulators endowed with multiple beneficial side effects for cystic fibrosis patients: toward a simplified therapeutic approach
Zhao et al. Baylis–Hillman adducts as a versatile module for constructing fluorogenic release system
Li et al. Functional bioprobe for responsive imaging and inhibition of amyloid-β oligomer based on curcuminoid scaffold
Wang et al. In‐vivo two‐photon visualization and quantitative detection of redox state of cancer